Anaphylaxis Treatment Market: Introduction
- Anaphylaxis is a serious, potentially life threatening allergic reaction likely to occur within minutes or seconds when exposed to the allergen. Anaphylaxis causes the immune system to release chemicals by sending the body into a state of shock wherein blood pressure drops and airways are narrowed, thus posing difficulty in breathing. Its symptoms include weak pulse, skin rash, low blood pressure, rapid pulse, nausea, and vomiting, which could be triggered by specific foods, medications, insect venom, etc. This condition is likely to have a major impact on children especially allergic to peanuts, fish, shellfish, tree nuts, etc. In adults, anaphylaxis trigger include OTC drugs, antibiotics, bee stings, latex, etc.
- As per a journal published on NCBI (National Center for Biotechnology Information) in 2017, up to 5% of the U.S. population suffered from the anaphylaxis condition. Moreover, as estimated, 1% of total hospitalizations and 0.1% of emergency attendances for anaphylaxis would have fatal outcomes. Drugs are a major cause of fatal anaphylaxis in various countries, such as Australia, New Zealand, the U.K., Brazil, and the U.S. As per a journal published on NCBI, in year 2018, the lifetime prevalence of the anaphylaxis is estimated to be 0.05% – 2% in the U.S., and approx. 3% in the Europe. Overall, the fatality of anaphylaxis condition is relatively low across the globe.
Get an Idea about the Offerings of Our Anaphylaxis Treatment Market Report from this Brochure
Key Drivers and Restraints of Global Anaphylaxis Treatment Market
- Rise in patient pool suffering from allergies across the globe is a major factor driving the anaphylaxis treatment market. Large unmet medical needs, changing lifestyle, and food habits are vastly impacting the growth of the global anaphylaxis treatment market. Awareness about allergy tests is expected to prevent the anaphylaxis condition. Early diagnosis of allergic reactions as a result of advanced tests is likely to drive the global anaphylaxis treatment market. Recent approvals of Epinephrine auto injectors and other drugs are likely to boost the anaphylaxis treatment market.
- Advanced diagnostic techniques are used in developed economies, such as the North America and Europe as compared to developing economies. However, rise in awareness about various diagnostic tests for allergies is expected to propel their adoption in emerging economies of Asia and Latin America. Moreover, availability of various routes of administration for immediate treatment is expected to drive the global market. Although, various risk factors, such as age and asthma, result in comorbidities, along with other disease complications. However, side effects of drugs for this allergy is anticipated to act as a restraining factor for the global anaphylaxis treatment market.
North America to Lead Global Anaphylaxis Treatment Market
- In terms of region, the global anaphylaxis treatment market can be divided into: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America dominated the global anaphylaxis treatment market, owing to the rise in patient pool suffering from the condition. Additionally, awareness about allergic tests and fatalities due to various allergic condition are projected to fuel the growth of the anaphylaxis treatment market in the region. Moreover, lifestyle changes, early diagnosis of specific allergies, and availability of anaphylaxis treatment are likely to boost the expansion of the anaphylaxis treatment market in North America. Key players in the region are focusing on launching innovative products, including the generic version of epinephrine, for the anaphylaxis condition. This is projected to propel market growth in in the region.
- Europe is another region with growing incidences of the anaphylaxis condition. However, the region is witnessing fast adoption of novel products in the anaphylaxis treatment. For instance, companies, such as Mylan, have introduced cheaper and generic version of EpiPen, which is contributing to market growth in the region.
- Asia Pacific is the rapidly emerging market for anaphylaxis treatment with rising awareness about the anaphylaxis condition. Awareness, adoption of allergy tests, and developing health care infrastructure coupled with large unmet medical needs are few factors responsible for the market growth in Asia Pacific.
Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom Anaphylaxis Treatment Market Report
Key Manufacturers Operating in Global Anaphylaxis Treatment market
The global anaphylaxis treatment market is highly consolidated. Key manufacturers operating in the global anaphylaxis treatment market are:
- Pfizer Inc.
- Mylan N.V.
- GlaxoSmithKline plc.
- Amneal Pharmaceuticals
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- Adamis Pharmaceutical Corporation
Global Anaphylaxis Treatment Market: Research Scope
Global Anaphylaxis Treatment Market, by Drug Class
Global Anaphylaxis Treatment Market, by Route of Administration
Global Anaphylaxis Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Anaphylaxis Treatment Market, by Region
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.